Skip to main content
Veterinary Medicines

OESTRACTON 52.4 micrograms/ml solution for injection for cattle, horses, pigs

Authorised
  • Gonadorelin (6-D-phenylalanine) acetate

Product identification

Medicine name:
OESTRACTON 52.4 micrograms/ml solution for injection for cattle, horses, pigs
OESTRACTON SOLUTION INJECTABLE POUR BOVINS CHEVAUX ET PORCS
Active substance:
  • Gonadorelin (6-D-phenylalanine) acetate
Target species:
  • Pig
  • Cattle
  • Horse
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Gonadorelin (6-D-phenylalanine) acetate
    52.40
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA01
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s)
  • (ID2) 60 millilitre(s): unspecified outer container with 6 Vial (Glass) each with 10 millilitre(s)
  • (ID1) 10 millilitre(s): unspecified outer container with 1 Vial (Glass) with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1289359 1/2013
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0154/001
Concerned member states:
  • Belgium
  • Czechia
  • France
  • Hungary
  • Ireland
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
French (PDF)
Published on: 7/04/2022